New monoclonal antibodies targeting ACE2 receptor could treat the next waves of SARS-CoV-2
Research led by Rockefeller University in New York investigated alternate targets for monoclonal antibodies to combat SARS-CoV-2 infections.
Research led by Rockefeller University in New York investigated alternate targets for monoclonal antibodies to combat SARS-CoV-2 infections.
If your infant or child is older than 6 months and has a fever, they probably do not need to be treated for the fever unless they are uncomfortable.
Dec 30, 2022
0
7
A woman has died from H3N8 bird flu in China, the World Health Organization reported Tuesday—the first known human fatality from the avian influenza strain.
Apr 11, 2023
0
147
For years, there has been a long-held belief that acute viral infections like Zika or COVID-19 are directly responsible for neurological damage, but researchers from McMaster University have now discovered that it's the immune ...
Feb 5, 2024
0
126
An international study led by MELIS-UPF researchers from the Infection Biology and Molecular Virology laboratories has identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor. SLFN 12 shuts down ...
May 10, 2023
0
82
An international study led by researchers from the Infection Biology Laboratory at the UPF Department of Medicine and Life Sciences (MELIS) establishes that one type of dendritic cell is crucial for the success of immunotherapeutic ...
Feb 16, 2023
0
49
Scientists at UC Riverside have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies or the immunocompromised.
Apr 15, 2024
0
203
Repeated outbreaks of bat-derived coronaviruses among humans and other mammals have heightened the need for a broad range of therapeutics—monoclonal antibodies and antivirals—treatments that can come immediately "off-the-shelf" ...
Researchers are investigating whether the COVID virus can affect vision and depth-perception of those infected.
Dec 21, 2022
0
85
An experimental vaccine for Marburg virus—a deadly cousin of the infectious agent that causes Ebola—can protect large animals from severe infections for up to a year with a single shot, scientists have found in a new ...